Apologies Well, sometimes it happens. The September issue of the HSI Members Alert featured an article titled, "Omega-3 fatty acids: Panacea or poison for prostate patients?" written by Charles Myers, M.D. The text refers to the "risks of glucosamine." Instead, that sentence SHOULD have read, "risks of chondroitin sulfate." There is absolutely no evidence that glucosamine contributes to the risk or growth of prostate cancer. Supplements containing chondroitin sulfate and glucosamine, two essential parts of cartilage, have been shown to slow and even reverse osteoarthritis, a degenerative joint disease. But while chondroitin sulfate may offer hope for arthritis patients, Dr. Myers has found convincing evidence that it can trigger prostate cancer growth and cause the cancer to spread to other sites. We apologize to our members and to Dr. Myers for any confusion created by this error. Dr. Myers is the Editor-in-Chief of "Prostate Forum" and the founder of the American Institute for Disease of the Prostate in Charlottesville, VA. For more information about his clinic and publications, call 434-974-1303, or log onto www.prostateforum.com. To Your Good Health, Jenny Thompson
Health Sciences Institute
| 
